Global genotype distribution of human clinical isolates of New Delhi metallo-β-lactamase-producing Klebsiella pneumoniae; A systematic review

Roca, 2015, The global threat of antimicrobial resistance, science for intervention., 6, 22 Lee, 2012, Carbapenem therapy for bacteremia due to extended-spectrum-β-lactamase-producing Escherichia coli or Klebsiella pneumoniae, implications of ertapenem susceptibility., 56, 2888 Rodríguez-Baño, 2018, Treatment of infections caused by extended-spectrum-beta-lactamase-, AmpC-, and carbapenemase-producing, Enterobacteriaceae., 31, e00079 Eshetie, 2015, Multidrug resistant and carbapenemase producing Enterobacteriaceae among patients with urinary tract infection at referral Hospital, Northwest Ethiopia, Antimicrobial resistance and infection control, 4, 12, 10.1186/s13756-015-0054-7 Hoang, 2019, Emergence of New Delhi Metallo-Beta-Lactamase (NDM) and Klebsiella pneumoniae Carbapenemase (KPC) Production by Escherichia coli and Klebsiella pneumoniae in Southern Vietnam and Appropriate Methods of Detection: A Cross-Sectional Study, BioMed research international, 2019, 10.1155/2019/9757625 Day, 2013, Prevalence of NDM‐1 carbapenemase in patients with diarrhoea in Pakistan and evaluation of two chromogenic culture media, Journal of applied microbiology, 114, 1810, 10.1111/jam.12171 Maltezou, 2009, Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece), Journal of Infection., 58, 213, 10.1016/j.jinf.2009.01.010 Karabay, 2016, The carbapenem-resistant Enterobacteriaceae threat is growing: NDM-1 epidemic at a training hospital in Turkey, Annals of clinical microbiology and antimicrobials, 15, 6, 10.1186/s12941-016-0118-4 Tamariz, 2018, Draft genome sequence of the first New Delhi metallo-β-lactamase (NDM-1)-producing Escherichia coli strain isolated in Peru, Genome Announc., 6, 10.1128/genomeA.00199-18 Torres-González, 2015, Outbreak caused by Enterobacteriaceae harboring NDM-1 metallo-β-lactamase carried in an IncFII plasmid in a tertiary care hospital in Mexico City, Antimicrobial agents and chemotherapy, 59, 7080, 10.1128/AAC.00055-15 Gonçalves, 2016, Outbreaks of colistin-resistant and colistin-susceptible KPC-producing Klebsiella pneumoniae in a Brazilian intensive care unit, Journal of Hospital Infection., 94, 322, 10.1016/j.jhin.2016.08.019 Walsh, 2005, Metallo-β-lactamases: the quiet before the storm?, Clinical microbiology reviews, 18, 306, 10.1128/CMR.18.2.306-325.2005 Queenan, 2007, Carbapenemases: the versatile β-lactamases, Clinical microbiology reviews, 20, 440, 10.1128/CMR.00001-07 Cornaglia, 2011, Metallo-β-lactamases: a last frontier for β-lactams?, The Lancet infectious diseases, 11, 381, 10.1016/S1473-3099(11)70056-1 Hall, 2005, Revised Ambler classification of β-lactamases, Journal of Antimicrobial Chemotherapy., 55, 1050, 10.1093/jac/dki130 Sheu, 2019, Infections caused by carbapenem-resistant Enterobacteriaceae: an update on therapeutic options, Frontiers in microbiology, 10 Asokan, 2019, WHO Global Priority Pathogens List: A Bibliometric Analysis of Medline-PubMed for Knowledge Mobilization to Infection Prevention and Control Practices in Bahrain, Oman medical journal, 34, 184, 10.5001/omj.2019.37 Dadashi, 2019, Frequency Distribution, Genotypes and the most Prevalent Sequence Types of New Delhi Metallo-beta-lactamase-Producing Escherichia coli among, Clinical Isolates around the World; A Review. Dadashi, 2017, Prevalence of blaNDM− 1-producing Klebsiella pneumoniae in Asia, A systematic review and meta-analysis, 19, 58 Dadashi, 2016, Evaluation of antibacterial effects of Zataria multiflora Boiss extracts against ESBL-producing, Klebsiella pneumoniae strains., 6, 336 Hasani, 2017, Integron-Mediated Multidrug and Quinolone Resistance in Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae, Archives of Pediatric Infectious Diseases., 5, 10.5812/pedinfect.36616 Paczosa, 2016, Klebsiella pneumoniae: going on the offense with a strong defense, Microbiol Mol Biol Rev., 80, 629, 10.1128/MMBR.00078-15 Hajjej, 2016, Successful treatment of a Carbapenem-resistant Klebsiella pneumoniae carrying blaOXA-48, blaVIM-2, blaCMY-2 and blaSHV-with high dose combination of imipenem and amikacin, IDCases., 4, 10, 10.1016/j.idcr.2016.01.003 Rolain, 2010, New Delhi metallo-beta-lactamase (NDM-1): towards a new pandemia?, Clinical Microbiology and Infection., 16, 1699, 10.1111/j.1469-0691.2010.03385.x Hammoudi Halat, 2020, The Current Burden of Carbapenemases: Review of Significant Properties and Dissemination among Gram-Negative Bacteria, Antibiotics (Basel)., 9 Cui, 2019, Carbapenemases in Enterobacteriaceae: detection and antimicrobial therapy, Frontiers in microbiology, 10, 1823, 10.3389/fmicb.2019.01823 Ahmad, 2018, Detection of New Delhi metallo-β-lactamase variants NDM-4, NDM-5, and NDM-7 in Enterobacter aerogenes isolated from a neonatal intensive care unit of a North India Hospital: a first report, Microbial Drug Resistance., 24, 161, 10.1089/mdr.2017.0038 Li, 2018, Dissemination of bla NDM-5 gene via an IncX3-type plasmid among non-clonal Escherichia coli in China, Antimicrobial Resistance & Infection Control., 7, 59, 10.1186/s13756-018-0349-6 van Duin, 2017, The global epidemiology of carbapenemase-producing Enterobacteriaceae, Virulence., 8, 460, 10.1080/21505594.2016.1222343 Albiger, 2015 Iregui, 2018, Carbapenemases in New York City: the continued decline of KPC-producing Klebsiella pneumoniae, but a new threat emerges, Journal of Antimicrobial Chemotherapy., 73, 2997, 10.1093/jac/dky322 Shen, 2017, Detection of an Escherichia coli sequence type 167 strain with two tandem copies of blaNDM-1 in the chromosome, Journal of clinical microbiology, 55, 199, 10.1128/JCM.01581-16 Diancourt, 2005, Multilocus sequence typing of Klebsiella pneumoniae, nosocomial isolates., 43, 4178 Khan, 2017, Structure, genetics and worldwide spread of New Delhi metallo-β-lactamase (NDM): a threat to public health, BMC microbiology, 17, 101, 10.1186/s12866-017-1012-8 Yu, 2019, Dissemination of Klebsiella pneumoniae ST11 isolates with carbapenem resistance in integrated and emergency intensive care units in a Chinese tertiary hospital, Journal of medical microbiology, 68, 882, 10.1099/jmm.0.000981 Chen, 2018, Emergence and nosocomial spread of ST11 carbapenem-resistant Klebsiella pneumoniae co-producing OXA-48 and KPC-2 in a regional hospital in Taiwan, Journal of medical microbiology, 67, 957, 10.1099/jmm.0.000771 Jiang, 2015, Tracking a hospital outbreak of KPC-producing ST11 Klebsiella pneumoniae with whole genome sequencing, Clinical Microbiology and Infection., 21, 1001, 10.1016/j.cmi.2015.07.001 Fu, 2019, Pandemic spread of blaKPC-2 among Klebsiella pneumoniae ST11 in China is associated with horizontal transfer mediated by IncFII-like plasmids, International journal of antimicrobial agents, 54, 117, 10.1016/j.ijantimicag.2019.03.014 Giske, 2012, Diverse sequence types of Klebsiella pneumoniae contribute to the dissemination of blaNDM-1 in India, Sweden, and the United Kingdom, Antimicrobial agents and chemotherapy, 56, 2735, 10.1128/AAC.06142-11 Navon-Venezia, 2017, Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance, FEMS microbiology reviews, 41, 252, 10.1093/femsre/fux013 Fortini, 2016, Double copies of blaKPC-3:: Tn4401a on an IncX3 plasmid in Klebsiella pneumoniae successful clone ST512 from Italy, Antimicrobial agents and chemotherapy, 60, 646, 10.1128/AAC.01886-15 Mavroidi, 2016, Characterization of ST258 colistin-resistant, bla KPC-producing Klebsiella pneumoniae in a Greek Hospital, Microbial drug resistance, 22, 392, 10.1089/mdr.2015.0282 Huang, 2018, Characteristics of NDM-1-producing Klebsiella pneumoniae ST234 and ST1412 isolates spread in a neonatal unit, BMC microbiology, 18, 1, 10.1186/s12866-018-1334-1 Wei, 2015, New Delhi metallo-β-lactamase-mediated carbapenem resistance: origin, diagnosis, treatment and public health concern, Chinese medical journal, 128, 1969, 10.4103/0366-6999.160566 Poirel, 2017, Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes, Clinical microbiology reviews, 30, 557, 10.1128/CMR.00064-16 Shields R. Aztreonam Combination Therapy: A Long-Awaited Answer to Metallo-β-Lactamase-Producing Gram-Negatives? Clinical Infectious Diseases. Emeraud, 2019, Aztreonam plus clavulanate, tazobactam, or avibactam for treatment of infections caused by metallo-β-lactamase-producing Gram-negative bacteria, Antimicrobial agents and chemotherapy, 63, 10.1128/AAC.00010-19